Cancer BiologybioRxivPreprint
Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells
Y. Shi, M. Dolan, M. Mastri…·J. M. L. Ebos
This study identifies an IFN-stimulated secretory program in PD-L1-resistant tumors that promotes immune evasion and shows that targeting this program can inhibit tumor growth.
DOI 10.1101/2021.07.01.450417